REGENXBIO Inc.RGNXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+13.8%
5Y CAGR+17.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+13.8%/yr
vs +54.2%/yr prior
5Y CAGR
+17.6%/yr
Recent deceleration
Acceleration
-40.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.2x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $80.30M | +139.2% |
| 2024 | $33.57M | -9.8% |
| 2023 | $37.21M | -31.8% |
| 2022 | $54.55M | +5.2% |
| 2021 | $51.83M | +45.1% |
| 2020 | $35.71M | +333.4% |
| 2019 | $8.24M | -14.5% |
| 2018 | $9.64M | +464.1% |
| 2017 | $1.71M | +78.2% |
| 2016 | $959000.00 | - |